SupplySide Supplement Journal’s Post

Not all liposomal products contain liposomes! Learn what it takes to validate a liposome in this great downloadable infographic from Natural Products Insider. #TruLiposomeValidated #LipoVantage #Liposomes #NaturalProducts

💡 Innovation in freeze-drying: Protect your products with Lyophitech! ❄️ ❄️ ❄️ We've rethought freeze-drying to offer optimum protection for your products, your teams and your processes. 🚀 ✅ Fully confined flow management ✅ Oxygen exposure eliminated: stability and quality preserved ✅ Reduced risk of spillage: a safe, controlled process in beads ✅ Optimal staff protection: fewer constraints, greater safety ✅ Easy cleaning: CIP & SIP 💬 Looking for a high-performance solution for your active and sensitive Products? Discover how our technology is revolutionizing freeze-drying! 👉 Let's talk about it! contact@lyophitech.fr #Lyophilization #Innovation #Safety #Pharmaceuticalindustry #API #FDF #Peptides #Oligo #Probiotics #Nucleotides #Humanhealth

STRIPPSOL® (www.aei24.com) is a line of products from AEI24 presented in fast dissolving oral films and specially created for everyday use allowing responding to the different needs of each person. STRIPPSOL® is manufactured using an innovative and cutting-edge technology called MultiLAY®, that is path breaking for the future and has its own identity due to high bioavailability, scalability and quality. MultiLAY® technology allows that the active ingredients can be placed layered into a thin strip without the use of a multitude of excipients that are used in conventional dosage forms. This novel technology has also made it possible to mask unpleasant tastes of the actives, making it very pleasant and delicious to ingest. STRIPPSOL® fast dissolving oral films presentation also offers a set of advantages compared to other oral dosage forms: It’s possible to reduce dosage improving efficacy and safety when used, improve the onset of action, reduce the time of dissolution and absorption, in addition to improving stability and making it more convenient and enjoyable for the consumer. If you want to stay updated, follow our page.(www.aei24.com)

Ingredient innovators such as Specnova are deeply committed to advancing the field through substantial investments in research and clinical studies, thereby demonstrating the significant value of their ingredients. When selecting a liposome supplier, it's crucial to choose a partner that not only substantiates the authenticity of their liposomes but also actively supports research that validates their effectiveness. Have questions? Contact Chris Obertlik or email us at contactus@specnova.com #Liposomes #LipoVantage #NaturalIngredients #TruLiposomeValidation

New Article Published! 📚 The newly published study explores the #DiluCap® line of excipients, designed to optimize capsule formulations. We tested dissolution profiles of capsules with APIs such as minoxidil, finasteride, melatonin, and naltrexone under simulated gastrointestinal conditions. These results highlight how #DiluCap® excipients can support multiple purposes in compounding pharmacies—ensuring API performance and improving bioavailability. You can read this and other articles published by Fagron at: https://lnkd.in/emk3CjnA

Mannitol are widely used as sweeteners and pharma excipients because of its features-Cool sweetness;Low-sugar and low calorie;Good stability;Low hygroscopicity;Natural dehydration Agent. For Pharma Grade, match to standard USP/BP/EP/IP/JP

L-glutamine is an essential amino acid required for cell culture growth. The typical concentration of L-glutamine in media is 292 mg/L or 2 mM. L-glutamine is not stable for long periods of time unless it is frozen. The material should be aliquoted to smaller volumes and then frozen. https://lnkd.in/gaH-KCR7

𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗘𝘃𝗮𝗹𝘂𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗟𝗮𝗰𝘁𝗼𝘀𝗲-𝗙𝗿𝗲𝗲 𝗦𝗶𝗻𝗴𝗹𝗲-𝗨𝗻𝗶𝘁 𝗮𝗻𝗱 𝗠𝘂𝗹𝘁𝗶𝗽𝗹𝗲-𝗨𝗻𝗶𝘁 𝗣𝗿𝗲𝗽𝗮𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗼𝗳 𝗮 𝗕𝗖𝗦 𝗖𝗹𝗮𝘀𝘀 𝗜𝗜 𝗗𝗿𝘂𝗴, 𝗥𝗶𝘃𝗮𝗿𝗼𝘅𝗮𝗯𝗮𝗻 by Daniel Zakowiecki , Peter Edinger , Markos Papaioannou , Michael Wagner ,Tobias Hess,  Jadwiga Paszkowska , Marcela Staniszewska , Daria Myslitska , Michał Smoleński , Justyna Dobosz , Grzegorz Garbacz  and Dorota Haznar-Garbacz   The aim of the present study was to develop lactose-free formulations of rivaroxaban, a novel oral anticoagulant used for the treatment and prevention of blood clotting. As a BCS Class II drug, rivaroxaban is characterized by poor solubility in aqueous media, posing a significant formulation challenge. To address this, phosphate-based excipients were employed to prepare both traditional single-unit dosage forms (tablets) and modern multiple-unit pellet systems (MUPS). These formulations were successfully developed and thoroughly evaluated for their physical properties and performance. Read more in the article. #excipients by Budenheim SE Tylose GmbH & Co. KG Shin-Etsu BIOGRUND

PHARMALACT: Your Key to Consistent Formulations Looking for lactose that delivers every time? PHARMALACT offers unmatched purity and performance, so your process stays seamless. Let’s discuss how we can help! #PHARMALACT #PharmaInnovation #ReliableIngredients #UtahTradingLLC #PharmaceuticalIndustry #RawMaterials

Do you know the difference between a good and bad lyocake? 🤔 If you're struggling to achieve the perfect lyocake, look no further – Biopharma Group is here to help. Whether you need support optimising your formulation or developing a robust cycle, we have the expertise to meet all your freeze-drying needs. Contact us to learn more. 🌐 #Lyocake #FreezeDrying #Lyophilisation